MEYER ALAN R 4
4 · Ocuphire Pharma, Inc. · Filed Nov 13, 2020
Insider Transaction Report
Form 4
MEYER ALAN R
Director
Transactions
- Award
Stock Option (right to buy)
2020-11-11+7,500→ 7,500 totalExercise: $4.05Exp: 2030-11-11→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]Vesting in 12 equal monthly increments beginning on November 30, 2020.